Intrinsic Value of S&P & Nasdaq Contact Us

MannKind Corporation MNKD NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
58/100
2/7 Pass
SharesGrow Intrinsic Value
$12.62
+360.6%
Analyst Price Target
$9.00
+228.5%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

MannKind Corporation (MNKD) trades at a trailing P/E of 136.2, forward P/E of 28.8. Trailing earnings yield is 0.73%, forward earnings yield 3.47%. PEG 0.08 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (62/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.08); analyst target implies upside (+228.5%).
  • Forward P/E 28.8 (down from trailing 136.2) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 0.08 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 0.73% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 3.47% as earnings recover.
  • Analyst consensus target $9.00 (+228.5% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 58/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
58/100
SG Score
View full scorecard →
VALUE
62/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
52/100
Analyst consensus
→ Forecast
~
PAST
50/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
64/100
→ Income
GROWTH
100/100
→ Income
INCOME
30/100
→ Income

Valuation Snapshot — MNKD

Valuation Multiples
P/E (TTM)136.2
Forward P/E28.8
PEG Ratio0.08
Forward PEG0.08
P/B Ratio-15.65
P/S Ratio2.31
EV/EBITDA23.1
Per Share Data
EPS (TTM)$0.02
Forward EPS (Est.)$0.10
Book Value / Share$-0.17
Revenue / Share$1.14
FCF / Share$0.04
Yields & Fair Value
Earnings Yield0.73%
Forward Earnings Yield3.47%
Dividend Yield0.00%
SharesGrow IV$12.62 (+360.6%)
Analyst Target$9.00 (+228.5%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 2.3 -0.02 -1.60 1.68 -
2017 -2.1 0.01 -1.12 20.51 -
2018 -1.8 0.04 -0.87 5.48 -
2019 -4.9 0.10 -1.32 4.00 -
2020 -12.2 0.75 -3.86 10.69 -
2021 -13.5 -0.32 -5.20 14.44 -
2022 -15.5 -0.82 -5.41 13.58 -
2023 -81.4 0.91 -3.95 4.89 -
2024 64.0 -0.20 -22.39 6.18 -
2025 295.6 -3.69 -33.97 4.97 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $1.36 $174.76M $125.66M 71.9%
2017 $-1.13 $11.75M $-117.33M -999%
2018 $-0.60 $27.86M $-86.98M -312.2%
2019 $-0.31 $63.04M $-59.73M -94.8%
2020 $-0.26 $65.14M $-57.24M -87.9%
2021 $-0.37 $75.44M $-91.79M -121.7%
2022 $-0.44 $99.77M $-112.17M -112.4%
2023 $-0.04 $198.96M $-11.94M -6%
2024 $0.10 $285.5M $27.59M 9.7%
2025 $0.02 $348.97M $5.86M 1.7%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.01 $-0.04 – $0.03 $467.59M $448.44M – $486.01M 5
2027 $0.11 $-0.03 – $0.25 $527.74M $375.76M – $586.78M 5
2028 $0.10 $-0.11 – $0.24 $530.84M $520.77M – $540.91M 7
2029 $0.20 $0.16 – $0.22 $597.24M $494.06M – $643.49M 2
2030 $0.42 $0.33 – $0.46 $730.26M $604.1M – $786.81M 5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message